Gamma‐Glutamyl Transpeptidase‐to‐Platelet ratio predicts liver fibrosis in patients with concomitant chronic hepatitis B and nonalcoholic fatty liver disease

The aim of this study was to compare the correlation of gamma‐glutamyl transpeptidase‐to‐platelet ratio (GPR), aspartate aminotransferase‐to‐platelet ratio index (APRI), fibrosis index‐4 (FIB‐4), and liver stiffness measurement (LSM) in the diagnosis of liver fibrosis, and perform a diagnostic value of GPR for predicting fibrosis in CHB patients with NAFLD.

[1]  Zhan-qing Zhang,et al.  INR-to-platelet ratio (INPR) as a novel noninvasive index for predicting liver fibrosis in chronic hepatitis B , 2021, International journal of medical sciences.

[2]  Hirokazu Takahashi,et al.  Diagnostic Accuracy of FibroScan and Factors Affecting Measurements , 2020, Diagnostics.

[3]  D. Lau,et al.  A New Endemic of Concomitant Nonalcoholic Fatty Liver Disease and Chronic Hepatitis B , 2020, Microorganisms.

[4]  Wei Liu,et al.  Prognostic value of combined preoperative gamma-glutamyl transpeptidase to platelet ratio and fibrinogen in patients with HBV-related hepatocellular carcinoma after hepatectomy. , 2020, American journal of translational research.

[5]  Qiankun Hu,et al.  Accuracy of FibroScan in analysis of liver fibrosis in patients with concomitant chronic Hepatitis B and nonalcoholic fatty liver disease , 2020, Medicine.

[6]  Ashish Kumar,et al.  Performance of Non-invasive Blood Parameters for Ruling Out Significant Liver Fibrosis in Patients with Chronic Hepatitis B , 2020, Journal of clinical and translational hepatology.

[7]  V. Wong,et al.  FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study , 2020, The lancet. Gastroenterology & hepatology.

[8]  M. N. Kim,et al.  Fibrosis-4, aspartate transaminase-to-platelet ratio index, and gamma-glutamyl transpeptidase-to-platelet ratio for risk assessment of hepatocellular carcinoma in chronic hepatitis B patients: comparison with liver biopsy , 2020, European journal of gastroenterology & hepatology.

[9]  H. Janssen,et al.  Nonalcoholic Steatohepatitis Is Associated With Liver‐Related Outcomes and All‐Cause Mortality in Chronic Hepatitis B , 2020, Hepatology.

[10]  [The guidelines of prevention and treatment for chronic hepatitis B (2019 version)]. , 2019, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

[11]  V. de Lédinghen,et al.  New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD. , 2019, Journal of hepatology.

[12]  M. Buti,et al.  Optimisation of the use of APRI and FIB-4 to rule out cirrhosis in patients with chronic hepatitis B: results from the SONIC-B study. , 2019, The lancet. Gastroenterology & hepatology.

[13]  M. Leshno,et al.  Liver steatosis is a strong predictor of mortality and cancer in chronic hepatitis B regardless of viral load , 2019, JHEP reports.

[14]  Jiming Zhang,et al.  Validation and comparison of seventeen noninvasive models for evaluating liver fibrosis in Chinese hepatitis B patients , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[15]  Sheng-Nan Lu,et al.  APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST level , 2018, PloS one.

[16]  Y. Uh,et al.  The gamma-glutamyl transferase to platelet ratio and the FIB-4 score are noninvasive markers to determine the severity of liver fibrosis in chronic hepatitis B infection , 2018, British journal of biomedical science.

[17]  B. Cai,et al.  Aspartate transaminase to platelet ratio index and gamma‐glutamyl transpeptidase‐to‐platelet ratio outweigh fibrosis index based on four factors and red cell distribution width‐platelet ratio in diagnosing liver fibrosis and inflammation in chronic hepatitis B , 2018, Journal of clinical laboratory analysis.

[18]  M. Yuen,et al.  Inverse relationship between hepatic steatosis and hepatitis B viremia: Results of a large case‐control study , 2018, Journal of viral hepatitis.

[19]  Jian Wang,et al.  Gamma-glutamyl-transpeptidase to platelet ratio is not superior to APRI,FIB-4 and RPR for diagnosing liver fibrosis in CHB patients in China , 2017, Scientific Reports.

[20]  Siddharth Singh,et al.  American Gastroenterological Association Institute Guideline on the Role of Elastography in the Evaluation of Liver Fibrosis. , 2017, Gastroenterology.

[21]  Liang Chen,et al.  The gamma-glutamyl transpeptidase to platelet ratio for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease , 2017, Oncotarget.

[22]  V. Wong,et al.  Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B , 2017, Journal of gastroenterology and hepatology.

[23]  C. Sirlin,et al.  Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis , 2017, Abdominal Radiology.

[24]  Liang Chen,et al.  The Gamma-Glutamyl-Transpeptidase to Platelet Ratio Does not Show Advantages than APRI and Fib-4 in Diagnosing Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis B , 2016, Medicine.

[25]  Gang Xu,et al.  Fibroscan improves the diagnosis sensitivity of liver fibrosis in patients with chronic hepatitis B , 2016, Experimental and therapeutic medicine.

[26]  G. Cooke,et al.  The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa , 2015, Gut.

[27]  Ling-jun Kong,et al.  Influence of Hepatic Inflammation on FibroScan Findings in Diagnosing Fibrosis in Patients with Chronic Hepatitis B. , 2015, Ultrasound in medicine & biology.

[28]  R. D. de Knegt,et al.  Evaluation of transient elastography for fibrosis assessment compared with large biopsies in chronic hepatitis B and C , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[29]  Hong Tang,et al.  [Accuracy of FibroScan for the diagnosis of liver fibrosis influenced by serum alanine aminotransferase levels in patients with chronic hepatitis B]. , 2011, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

[30]  V. Wong,et al.  Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B , 2008, Gut.

[31]  J. Montaner,et al.  Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection , 2006, Hepatology.

[32]  J. Kalbfleisch,et al.  A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C , 2003, Hepatology.